Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of ClearLLab Leukemia and Lymphoma Panels

NCT03413644 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT03413644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03413644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of ClearLLab Leukemia and Lymphoma Panels
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Completed
Start date
November 14, 2017
Completion date
April 27, 2018
Enrollment
482 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia-lymphoma